SC
Scilex Holding Company
SCLXW · NASDAQ
$0.09 -0.11% (-$0.00)
1M -47.12%
Market Cap $763.4K
P/E Ratio -
Div. Yield -
ROE -
Bulios Fair Price
$0.13
44.6% upside
Current Price
$0.09
Undervalued Fair Value Overvalued
According to Bulios Fair Price, SCLXW is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Weak
2/9Valuation
100 /100
Cheap P/S 0.02x
P/E N/A
P/FFO N/A
Growth
0 /100
Declining Rev. growth 7.35%
EPS growth N/A
Book val. growth N/A
Profitability
20 /100
Weak Gross margin 50.47%
FCF margin 56.69%
Net margin 1,418.45%
Quality
59 /100
Average ROIC 162.61%
Asset turnover 0.12x
ROA 176.82%
Debt
0 /100
High Current ratio 0.07x
Int. coverage -20.98x
Debt/Equity N/A
Stability
6 /100
Unstable Beta 1.74x
Profitable years 0
Rev. volatility 39.57%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about SCLXW
Online
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Henry H. Ji
Employees
34
Headquarters
Palo Alto
Upcoming events
02 DEC
Earnings
Upcoming earnings report